Perimeter Medical’s Strong Q1 Surge in Clinical Trials

Perimeter Medical Imaging Ai Inc (TSE:PINK) has released an update.

Perimeter Medical Imaging AI, Inc. reported robust first quarter 2024 financial results, revealing a surge in patient enrollment for its pivotal clinical trial of AI-enhanced OCT technology for breast-conserving surgeries. The company’s commercial expansion is on a strong trajectory with three new S-Series OCT systems placed in hospitals, highlighting growing market acceptance and peer recommendations. Significant research findings support the need for innovative margin visualization technology like Perimeter’s to potentially reduce high reoperation rates in breast surgery.

For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.